Minerva Neurosciences reported $-14246000 in Equity Capital and Reserves for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US USD 425.69M 9.16M
Adma Biologics ADMA:US USD 100.38M 14.02M
ALKERMES ALKS:US USD 1.04B 39.47M
AstraZeneca AZN:LN USD 35.13B 798M
Biocryst Pharmaceuticals BCRX:US USD -242659000 29.43M
Bristol Myers Squibb BMY:US USD 32.67B 71M
Eli Lilly And LLY:US USD 10.07B 1.53B
Esperion Therapeutics ESPR:US USD -294100000 2.4M
GlaxoSmithKline GSK:LN GBP 9.15B 7.22B
Halozyme Therapeutics HALO:US USD 96.99M 196.18M
IONIS PHARMACEUT IONS:US USD 594.36M 30.36M
Marinus Pharmaceuticals MRNS:US USD 82M 77.2M
Minerva Neurosciences NERV:US USD -14246000 5.86M
Neurocrine Biosciences NBIX:US USD 1.54B 121.2M
Novartis NOVN:VX USD 60.82B 2.1B
Novavax NVAX:US USD -565985000 149.04M
Takeda 4502:JP JPY 6.71T 396.1B
Vanda Pharmaceuticals VNDA:US USD 515.66M 7.11M